1 The retractions came only months after BioMed Central.

But that move may not be enough, as the publisher Hindawi discovered this past springtime. Although Hindawi doesn’t let authors suggest reviewers for their manuscripts, it decided to examine the peer-review information for manuscripts submitted in 2013 and 2014 for possible fraud. The peer-review procedure used in Hindawi’s journals depends primarily on the expertise of its editorial board members and the guest editors of special issues, who are responsible for supervising the overview of submitted manuscripts.5 Because the peer reviewers selected by the guest editors weren’t subject to any sort of independent verification, editors themselves could undermine the procedure in much the same way that authors or third-party agencies did elsewhere: by creating fake reviewer identities and addresses that they submitted positive reviews endorsing publication.This capital increase will help fund expansion plans and finance medical trials of its promising portfolio of MNM diagnostic and therapeutic products. The support we continue to receive is testament to the confidence of our shareholders in the continued growth and positive achievements of the Company and its solid business design. The money raised can help us accelerate our international growth, which include the expansion of our actions in america, and finance the advancement of our promising item pipeline.We think that AAA's approach to targeted therapy is very promising and can further advance innovation and product development in Molecular Nuclear Medication, a niche which has been poorly exploited until now.